Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-06

FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Parenteral Medicines, Inc.)

View source ↗

Summary

FDA approved Teva Parenteral Medicines, Inc.'s supplemental application for metoclopramide (ANDA073135), approving changes to the approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metoclopramide (metoclopramide)

Snippet

SUPPL AP for METOCLOPRAMIDE (METOCLOPRAMIDE)